{"data":{"id":"us-in/ic-16-18-2-199","jurisdiction":"us-in","citation":"IC 16-18-2-199","heading":"\"Legend drug\"","body":"Sec. 199. \"Legend drug\", for purposes of IC 16-42, means a drug that is:\n(1) subject to 21 U.S.C. 353(b)(1); or\n(2) listed in the Prescription Drug Product List as:\n(A) published in United States Department of Health and Human Services Approved Drug Products with Therapeutic Equivalence Evaluations, Tenth Edition, (1990); and\n(B) revised in United States Department of Health and Human Services, Approved Drug Products with Therapeutic Equivalence Evaluations, Cumulative Supplement to the Tenth Edition, Number 10 (1990).","path":["TITLE 16. HEALTH","ARTICLE 18. GENERAL PROVISIONS AND DEFINITIONS","Chapter 2. Definitions"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-18-2-199","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"b09bc2b9c7fc1f2e03546636bb2dbeb26867b3b3da6b874b606ddc250360086e","source_id":"us-in","stale":false,"prev":"us-in/ic-16-18-2-198.7","next":"us-in/ic-16-18-2-200"},"notice":"GroundRules: Original legal text. Not legal advice."}